Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

Analysts: Big Biotech will grow despite economy

fiercebiotech.com » 2008 » November » 26th » Analysts: Big Biotech will grow despite economy

Tagged: wall street, economic development, biotech stock, big biotech

Although they've fallen from the record highs posted in August, biotech stocks aren't as risky as many fear--or expensive, says a report by Barron's. Not surprisingly, Big biotech is doing better on Wall Street than their smaller counterparts, but they're is also doing better than the broader stock market and will continue to grow. Barron's report has a number of analysts touting Big Biotech's Continue Reading »


Latest news from :

  1. J&J, Vanderbilt ink rich partnering deal
  2. Array biopharma cuts staff, seeks partnerships
  3. Merck, Galapagos ink $233M obesity deal
  4. Orexigen Phase III obesity drug meets endpoints
  5. Alnylam, Cubist form RNAi partnership

Latest news from fiercebiotech.com:

  1. India drawing more clinical trials
  2. Crucell shares soar on Wyeth merger talks
  3. Plexxikon, Roche ink $335M development pact
  4. Onyx forges $550M pact for S*Bio programs
  5. Satori gains $22M to push Alzheimer's work